Cover Image
市場調查報告書

內臟器官·組織移植的全球市場

Organ and Tissue Transplantation

出版商 Global Industry Analysts, Inc. 商品編碼 236773
出版日期 內容資訊 英文 266 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
內臟器官·組織移植的全球市場 Organ and Tissue Transplantation
出版日期: 2016年11月01日 內容資訊: 英文 266 Pages
簡介

本報告提供全球內臟器官·組織移植市場相關調查分析,提供全球器官移植(心臟,腎臟,肝臟,肺,角膜移植)等各產品區隔考察,以及美國市場各內臟器官(心臟,腎臟,肝臟,胰臟,肺,腸),組織(角膜,心臟瓣膜,皮膚,血管,骨髓,骨),骨移植(自我移植,同類移植,其他)之用途別考察,美國,加拿大,日本,歐洲,亞太地區,南美,全球其他各國等市場別相關分析,再彙整今後的市場預測,過去6年的市場分析,主要企業簡介等相關資訊。

第1章 簡介,調查方法,產品定義

第2章 摘要整理

  • 市場概要
    • 市場預測
    • 現在與未來的分析
    • 內臟器官捐贈者概要
    • 最多的器官移植腎臟·肝臟移植
    • 供需的不平衡
    • 解決內臟器官不足的問題
    • 心臟麻痺死患者:潛在的捐贈者
    • 循環死亡後捐贈:充斥著倫理問題
    • 移植:支出和不同地區差異
    • 骨移植概要
    • 其他移植
  • 市場趨勢
  • 移植影響市場的主要因素
  • 產品概要
    • 器官移植
    • 心臟移植
    • 腎臟移植
    • 肝臟移植
    • 胰臟移植
    • 小腸移植
    • 肺移植
    • 心臟/肺移植
    • 組織移植
    • 移植的種類
    • 角膜移植
    • 血液幹細胞
    • 骨/組織移植
    • 骨髓移植
    • 心臟瓣膜
    • 胎兒細胞
    • 保存期限
    • 冷缺血時間
    • 移植免疫學
    • 急性細胞性排斥反應
    • 慢性排斥反應
    • 移植後觀察
    • 捐贈者的種類
    • 內臟器官/組織的提供和申請資格標準
    • 提供內臟器官和接收者的選配
    • 檢驗
    • 血型
    • 組織型
    • 組織適合性
    • 移植的安全必要條件
    • 等待候補名單
    • 歷史
    • 器官移植主要的里程碑
  • 人造器官:固態器官移植的替代品
  • 保存的解決方案,免疫抑制劑
  • 法規環境
  • 近來產業活動
  • 全球主要企業
  • 全球市場概要

第3章 市場

  • 美國
  • 加拿大
  • 日本
  • 歐洲
  • 亞太地區
  • 南美
  • 全球其他各國

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-1572

This report analyzes the worldwide markets for Organ and Tissue Transplantation in number of organs transplanted. The Global and regional markets (except the US) for Organ and Tissue Transplantation in this report are analyzed by the following Product Segments - Organ Tranplantation (Heart, Kidneys, Liver, Pancreas, Lungs, and Corneal Transplantation). The US market for Organ and Tissue Transplantation in this report is analyzed by the following Product Segments: Organ Type (In Volume and Value) (Heart, Kidneys, Liver, Pancreas, Lungs, and Intestine), Tissue Type (Volume Only) (Cornea, Heart Valve, Skin Grafts, Vascular Grafts, Bone Marrow, and Bone Grafts), and Bone Graft Transplantation (Volume Only) (By Graft Type: Autologous Graft, Allograft, and Other Materials; By Application Type: General Orthopedics, Spinal Fusions, and Cranio/Maxillofacial). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 22 companies including many key and niche players such as -

Acelity L.P. Inc.
CryoLife, Inc.
Exactech, Inc.
Folio Biosciences, LLC
Dr. Franz Kohler Chemie GmbH

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definition and Scope of Study
    • Organ Transplantation
      • Heart Transplantation
      • Kidney Transplantation
      • Liver Transplantation
      • Pancreas Transplantation
      • Small Intestine Transplantation
      • Lungs
    • Tissue Transplantation
      • Corneal Transplantation
      • Blood Stem Cell Transplantation
      • Bone Marrow Transplantation
      • Heart Valves Transplantation

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Market Outlook
  • Current & Future Analysis
  • A Review of Organ Donors Worldwide
    • Table 1: Global Organ Transplants Market (2014 & 2015): Number of Deceased Organ Donors per Million Population (PMP) for Select Countries (includes corresponding Graph/Chart)
    • Table 2: Global Organ Transplants Market (2014 & 2015): Number of Living Organ Donors per Million Population (PMP) for Select Countries (includes corresponding Graph/Chart)
  • Kidney and Liver Transplants Top the Organ Transplants Worldwide
    • Table 3: Global Kidney Transplants Market (2014): Number of Deceased Donors Per Million Population (PMP) for Select Countries (includes corresponding Graph/Chart)
    • Table 4: Global Kidney Transplants Market (2014): Number of Living Donors Per Million Population (PMP) for Select Countries (includes corresponding Graph/Chart)
    • Table 5: Global Liver Transplants Market (2014): Number of Deceased Donors Per Million Population (PMP) for Select Countries (includes corresponding Graph/Chart)
    • Table 6: Global Liver Transplants Market (2014): Number of Living Donors Per Million Population (PMP) for Select Countries (includes corresponding Graph/Chart)
    • Table 7: Global Heart Transplants Market (2014): Number of Transplants Per Million Population (PMP) for Select Countries (includes corresponding Graph/Chart)
    • Table 8: Global Lung Transplants Market (2014): Number of Transplants Per Million Population (PMP) for Select Countries (includes corresponding Graph/Chart)
    • Table 9: Global Pancreas Transplants Market (2014): Number of Transplants Per Million Population (PMP) for Select Countries (includes corresponding Graph/Chart)
  • Demand and Supply Imbalance
  • Measures to Address Organ Shortage...
  • Cardiac Arrest Death Patients: The Untapped Potential Donors
    • Table 10: Global Organ Transplants Market (2014): Number of Actual Donors After Cardiac Death per Million Population (PMP) by Select Country (includes corresponding Graph/Chart)
  • Donation after Circulatory Death - Rife with Ethical Issues
  • Transplantation - Expenditure and Regional Variations
    • Table 11: US Organ Transplantation Charges - Total Billed Charges per Transplant by Type (2014) (includes corresponding Graph/Chart)
  • Bone Grafts: An Overview
    • Table 12: Fractures by Age Group (2014): Percentage Share Breakdown of Number of Fractures by Age Group (includes corresponding Graph/Chart)
    • Table 13: Global Orthopedic Market by Segment (2015E): Percentage Breakdown of Value Sales for Extremities, Hips, Knees, Orthobiologics, Spine, Trauma and Others (includes corresponding Graph/Chart)
  • Orthopedic Grafts - Regional Market Variations

2. MARKET TRENDS

  • Combined Organ Transplantation - Gaining Attention
    • Table 14: Multiple Organ Transplants in the US - No. of Transplants by Type (2014- 2016) (includes corresponding Graph/Chart)
  • Illegal Organ Trafficking - A Risky Proposition
  • Transplant Tourism - Creating Brighter Avenues
  • Graying Population and Chronic Diseases Surge Need for Transplants
  • Global Aging Population Statistics - Opportunity Indicators
    • Table 15: Elderly Population (60+ Years) as a Percentage of Total Population (2015 & 2050) (includes corresponding Graph/Chart)
    • Table 16: Global Aging Population in Select Regions/ Countries: Population of 60+ Individuals in '000s and as a Percentage of Total Population for 2015 & 2050 (includes corresponding Graph/Chart)
    • Table 17: Life Expectancy at Age 60 and 80 Years - (2010-2015), (2020-2025) & (2045-2050) (includes corresponding Graph/Chart)
    • Table 18: Life Expectancy for Select Countries in Number of Years: 2015E (includes corresponding Graph/Chart)
  • Optimization Strategies for Organs Catch Attention and Supply-Demand Gap Widens
  • Advent of Innovative Devices Mitigate Chances of Organ Damages
  • Shortage of Organs Propels Research on Xenotransplantation
  • A Peek into the Organ Transplant Immunosuppressants Market
  • Market to Come Under Tremendous Pressure
  • Rising Incidences of Degenerative Intervertebral Disc Diseases Promote Tissue Transplantation
    • Table 19: % of Women Affected by Osteoporosis (includes corresponding Graph/Chart)
  • Fetal Tissue for Bionic Devices - Assuming Importance
  • LVADs - Gaining Significance for Impending Heart Transplants
  • Synthetic Bone Graft - The Latest Trend
  • Stem Cell Therapies - Expanding the Horizon of Transplantation
  • Rising Cancer Incidence to Drive Stem Cell Transplants
    • Table 20: Number of New Cancer Cases Worldwide by Affected Site: 2012 (in Thousands) (includes corresponding Graph/Chart)
  • Demineralized Bone Matrix (DBM): Strong Growth but Tough Competition
  • Bone Morphogenetic Protein - Safety Concerns Affect Growth Prospects
  • Dental Bone Grafting - A High Potential Market
    • Table 21: Dental Tissue & Bone Regeneration Materials Market (2015): Percentage Share Breakdown by Segment for Allografts, Synthetics, and Xenografts (includes corresponding Graph/Chart)
  • Key Recent Technological Innovations
  • 3-D Bioprinting
  • Preloaded Corneal Tissue Cartridges
  • Lung Perfusion Technology

3. MAJOR ISSUES IMPACTING TRANSPLANTATION MARKET

  • Organ Rejection - A Major Barrier to Transplantation
  • Scarcity of Donor Organs - A Stumbling Block in Organ Transplantation
  • Other Issues for Organ Transplantation
  • Ethical Concerns in Transplants
  • Bioethical Issues Hinder Organ Donation Process
  • Lack of Requisite Expertise - Hindering Implantation Process
  • Corneal Transplantation in Developing Countries: Key Challenges

4. PRODUCT OVERVIEW

  • Organ Transplantation
  • Heart Transplantation
    • Heart Diseases and Disorders
    • Post-Operative Complications and Consequences of Heart Transplants
      • Bleeding
      • Infection
      • Arrhythmia
      • Heart Attack
      • Coronary Artery Disease
      • Respiratory Dysfunction
      • Renal Dysfunction
      • Graft Rejection and Dysfunction
      • Death
  • Kidney Transplantation
    • Kidney Disorders and Diseases
    • Donor Evaluation
    • Waiting List
    • Surgery/Post-Operation
    • Post-Operative Supervision and Issues
  • Liver Transplantation
    • Liver Disorders and Diseases
  • Pancreas Transplantation
    • Post-Operative Complications and Consequences of Pancreas Transplants
  • Small Intestine Transplantation
    • Intestine Disorders and Diseases
  • Lung Transplantation
    • Lung Diseases and Disorders
    • Lung Patients Survival Statistics
  • Heart-and-Lung Transplantation
  • Tissue Transplantation
  • Types of Grafts
    • Autograft
    • Allograft / Homograft
      • Transplant Tolerance
    • Isograft
    • Xenograft
  • Corneal Transplantation
    • Penetrating Keratoplasty
    • Lamellar (Non-Penetrating) Keratoplasty
    • Aftercare
    • Risks Associated with Corneal Transplants
    • Transplantation Outcomes
    • Morbidity and Mortality Rates
    • Alternatives
  • Blood Stem Cells
    • Peripheral Blood Stem Cell Transplant
    • Umbilical Cord Blood Stem Cell Transplant
    • Bone Marrow and Hematopoietic Stem Cells
  • Bone and Tissue Transplantation
  • Bone Marrow Transplants
    • Stem Cell Therapy
  • Human Heart Valves
    • Atrioventricular Valves
      • Mitral Valve
      • Tricuspid Valve
    • Semilunar Valves
      • Aortic Valve
      • Pulmonic Valve
    • Pathology of Valves
    • Prosthetic Heart Valves
    • Prosthetic Mechanical Valve
      • Advantages
      • Disadvantages
    • Prosthetic Biologic Valve
      • Advantages
      • Disadvantages
  • Fetal Cells
    • Fetal Tissue for Transplantation
  • Storage Duration Time
    • Storage Time Period for Organs and Tissues
  • Cold Ischemia Time
  • Transplantation Immunology
  • Acute Cellular Rejection
  • Chronic Rejection
  • Post-Transplant Observations
  • Types of Donors
  • Alive Donors
  • Related Donors
  • Good Samaritans
  • Rewarded/Forced Donors
  • Deceased Donors
  • Directed / Allocated
    • Organs and Tissues Transplanted by Type of Donor
  • Organ/Tissue Donation and Eligibility Criteria
  • Factors Considered for Matching Recipients to Donor Organs
  • Testing
  • Blood Typing
  • Tissue Typing
  • Histocompatibility - A Major Barrier for Organ Transplantation
  • Transplantation - Safety Requirements
  • Waiting List
  • Active Waiting List Patients
  • Inactive Waiting List Patients
  • History
  • Major Milestones in Organ Transplantation

5. ARTIFICIAL ORGANS - AN ALTERNATIVE TO SOLID ORGAN TRANSPLANTS

  • Artificial Organs Revolutionize Medical Technology Industry
  • Artificial Organs
  • Categorization of Artificial Organs
    • External Artificial Organs
    • Internal or Implantable Artificial Devices
  • Artificial Heart
    • Total Artificial Heart (TAH)
    • Ventricle Assist Device (VAD)
      • Right Ventricular Assist Systems (RVAS)
      • Left Ventricular Assist Systems (LVAS)
      • Select Ventricular Assist Devices
  • Artificial Kidney (Dialyzer)
    • Limitations of Artificial Kidney
  • Artificial Liver
    • Select Liver Assist Devices
    • Categorization of Liver Devices
      • Mechanical Systems
      • Bio-Artificial Systems
  • Artificial Pancreas
  • Artificial Lungs (Oxygenator)
    • Types of Artificial Lung
  • Artificial Cornea
    • Keratoprostheses
    • Tissue Engineered Corneas
  • Artificial Skin/Skin Replacement Products
    • AlloDerm Regenerative Tissue Matrix
    • Apligraf
    • Cymetra Micronized AlloDerm Tissue
    • Dermagraft
    • Epicel
    • Integra Products
    • OrCel
    • TransCyte
  • Core Competitive Factors
  • Market Outlook for Artificial Organs

6. PRESERVATION SOLUTIONS & IMMUNOSUPPRESSANT DRUGS

  • Organ Preservation Solutions
  • Celsior Solution
  • Collins Solution
  • Euro Collins Solution
  • Custodiol(r) HTK Solution
  • Hypothermosol
  • ViaSpan
  • Immunosuppressant Drugs
  • Antibody Products for Treatment of Organ Transplant Rejection
    • Antithymocyte Globulin
    • ATGAM
    • Thymoglobulin
  • Therapeutic Antibody Products
    • Antiproliferative Agents
    • Azathioprine
    • CellCept
    • Certican
    • Myfortic
    • Calcineurin Inhibitors
      • Cyclosporine
      • Gengraf
      • Neoral
      • Prograf (Tacrolimus)
    • TOR Inhibitors
  • Side Effects of Immunosuppression Therapy

7. REGULATORY ENVIRONMENT

  • Transplant Center
  • Organ Procurement Organization (OPO)
  • Health Resources and Services Administration (HRSA)
  • Division of Transplantation (DoT)
  • United Network for Organ Sharing (UNOS)
  • Organ Procurement and Transplantation Network (OPTN)
  • University Renal Research and Education Association (URREA)
  • Scientific Registry of Transplant Recipients (SRTR)
  • Funding Sources
  • Patient Education and Advocacy Organizations
  • Legal Framework for Transplantation
  • Legislation Covering Organ Transplant
  • Organ Transplantation and Ethics

8. RECENT INDUSTRY ACTIVITY

  • Paragonix Technologies and Waters Medical Systems Enter into Product Supply Agreement
  • Medtronic Announces Availability of Beacon Heart Failure Management Service
  • Paragonix Technologies and Essential Pharmaceuticals Enter into Product Supply Agreement
  • LeMaitre Vascular Acquires ProCol(r) Distribution Rights and Purchase Option
  • Merit Medical Systems Purchases HeRO Graft Product Line of CryoLife
  • CryoLife Takes Over On-X Life Technologies
  • Medtronic Obtains FDA Clearance on Infuse(r) Bone Graft
  • Veloxis Pharmaceuticals Introduces Envarsus(r) XR for Kidney Transplant Treatment
  • Organogenesis Obtains Marketing Authorization on Apligraf(r) Wound Healing Technology
  • Medtronic Plc Introduces Medtronic CoreValve(r) System for Everyday Clinical Experience
  • Genomic Data Sciences Releases Unique Human Leukocyte Antigen (HLA) Typing Software Solution
  • St. Jude to Acquire Thoratec
  • Lifeline Scientific Obtains CFDA Clearance for Commercial Sale of Clinical Organ Preservation and Flush Solutions
  • Organovo and Yale Team Up to Develop Bioprinted Tissues for Surgical Transplantation
  • ThermoGenesis and TotipotentRX Complete 20th Pediatric BMT
  • LifeCell Acquires Adipose Tissue Injector from Tau Tona Group
  • AlloSource Introduces AlloMend(tm)
  • Synergy Biomedical Launches Bonegraft Product BioSphere Putty
  • K2M Launches Venado Bonegraft Systems
  • OTS Launches LifeCradle(r) Heart Perfusion System
  • FBiH Signs Agreement with Croatia
  • AlloSource and HumaCyte Enter Manufacturing Agreement
  • PSF Partners with MTF for Research Grants

9. FOCUS ON SELECT PLAYERS

  • Acelity L.P. Inc. (US)
  • CryoLife, Inc. (US)
  • Exactech, Inc. (US)
  • Folio Biosciences, LLC (US)
  • Dr. Franz Kohler Chemie GmbH (Germany)
  • Medtronic, plc. (Ireland)
  • Organogenesis, Inc. (US)
  • Organ Recovery Systems (US)
  • Organ Transport Systems (US)
  • XVIVO Perfusion AB (Sweden)

10. GLOBAL MARKET PERSPECTIVE

    • Table 22: World Recent Past, Current & Future Analysis for Organ Transplantation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 23: World Historic Review for Organ Transplantation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 24: World 14-Year Perspective for Organ Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
    • Table 25: World Recent Past, Current & Future Analysis for Heart Transplantation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 26: World Historic Review for Heart Transplantation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 27: World 14-Year Perspective for Heart Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
    • Table 28: World Recent Past, Current & Future Analysis for Kidney Transplantation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 29: World Historic Review for Kidney Transplantation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 30: World 14-Year Perspective for Kidney Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
    • Table 31: World Recent Past, Current & Future Analysis for Liver Transplantation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 32: World Historic Review for Liver Transplantation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 33: World 14-Year Perspective for Liver Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
    • Table 34: World Recent Past, Current & Future Analysis for Pancreas Transplantation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 35: World Historic Review for Pancreas Transplantation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 36: World 14-Year Perspective for Pancreas Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
    • Table 37: World Recent Past, Current & Future Analysis for Lung Transplantation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 38: World Historic Review for Lung Transplantation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 39: World 14-Year Perspective for Lung Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
    • Table 40: World Recent Past, Current & Future Analysis for Corneal Transplantation by Geographic Region - US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 41: World Historic Review for Corneal Transplantation by Geographic Region - US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 42: World 14-Year Perspective for Corneal Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Current & Future Analysis
    • Organ Transplant Sector Holds Growth Potential
    • Table 43: US Organ Donors by Type - Kidney, Liver, Heart, Lung, and Pancreas for the Years 2014, 2015 and 2016 (includes corresponding Graph/Chart)
    • Table 44: The US Bone Marrow Donor Registry: Percentage Breakdown of Adult Donors and Cord Blood Units by Race/Ethnicity (includes corresponding Graph/Chart)
    • Table 45: The US Kidney Donations by Donor Type (Deceased and Living): Number of Donors for 2014, 2015 and 2016 (includes corresponding Graph/Chart)
    • Table 46: The US Liver Donations by Donor Type (Deceased and Living): Number of Donors for 2014, 2015 and 2016 (includes corresponding Graph/Chart)
    • Table 47: The US Heart Donations by Donor Type - Deceased and Living: Number of Donors for 2014, 2015 and 2016 (includes corresponding Graph/Chart)
    • Table 48: The US Lung Donations by Donor Type - Deceased and Living: Number of Procedures for 2014, 2015 and 2016 (includes corresponding Graph/Chart)
    • Table 49: The US Pancreas Donations by Donor Type - Deceased and Living: Number of Procedures for 2014, 2015 and 2016 (includes corresponding Graph/Chart)
    • Table 50: The US Intestines Donations by Donor Type - Deceased and Living: Number of Procedures for 2014, 2015 and 2016 (includes corresponding Graph/Chart)
    • Table 51: The US Intestinal Transplants by Donor Type - Deceased and Living: Percentage Share Breakdown of Number of Procedures for 2014, 2015 and 2016 (includes corresponding Graph/Chart)
    • Table 52: The US Deceased Organ Donors (2016): Percentage Breakdown of Donors by Age Group (includes corresponding Graph/Chart)
    • Table 53: The US Live Organ Donors (2016): Percentage Breakdown of Donors by Age Group (includes corresponding Graph/Chart)
    • Table 54: The US Organ Transplant Market by Race (2015): Percentage Breakdown of Donors and Recipients for African-Americans, Caucasians, Hispanics and Others (includes corresponding Graph/Chart)
    • Waiting List for Organ Transplants in the US
    • Table 55: Waiting List of Patients for Organ Transplants in the US by Organ Type: As of November, 2016 (includes corresponding Graph/Chart)
    • Select Market Trends
      • Rising Incidence of ESRD in the US: A Business Case for Kidney Transplants
    • Table 56: ESRD Patient Prevalence in the US (2009-2014) (includes corresponding Graph/Chart)
      • Innovative Education Programs Contribute to Higher Organ Donors
      • Awareness Programs to Address Shortage of Minority Donors
      • US Organ Procurement Organizations by State
      • KPD Enables Compatibility Factor for Kidney Transplants
      • Tissue Transplantation in the US
    • Dental Bone Graft Substitutes Market: An Overview
      • Regulatory Challenges Limit Growth in the US Orthopedic Biomaterials Market
    • Rising Incidence of Degenerative Intervertebral Disc Diseases - Opportunity Indicators for Bone Grafts
      • Osteoporosis
    • Table 57: Osteoporosis Population in the US: 2002, 2005, 2008 & 2012 (includes corresponding Graph/Chart)
    • Table 58: Breakdown of Osteoporotic Fractures by Site in the US (includes corresponding Graph/Chart)
    • Regulatory Bodies
      • The United Network for Organ Sharing
      • The American Association of Tissue Banks (AATB)
      • Accredited Banks from Select US States
      • Eye Banks from Select US States
      • National Organ Transplant Act (NOTA)
      • Good Tissue Practices
      • Tissue Banking Regulation
      • FDA Regulations on Xenograft
      • DBM-based Products in US
      • Synthetic Bone Graft Substitutes
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • By Value Sales
    • Table 59: The US Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas, Lung and Intestine Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 60: The US Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas, Lung and Intestine Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 61: The US 14-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Dollar Sales for Heart, Kidney, Liver, Pancreas, Lung and Intestine Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
    • Table 62: The US Recent Past, Current & Future Analysis for Cornea Transplantation Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 63: The US Historic Review for Cornea Transplantation Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • By Number of Procedures
    • Table 64: The US Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas, Lung and Intestine Markets Independently Analyzed with Number of Procedures for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 65: The US Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas, Lung and Intestine Markets Independently Analyzed with Number of Procedures for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 66: The US 14-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas, Lung and Intestine Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
    • Table 67: The US Recent Past, Current & Future Analysis for Tissue Transplantation by Tissue Type - Cornea, Heart Valves, Skin Grafts, Vascular Grafts, Bone Marrow and Bone Grafts Markets Independently Analyzed with Number of Procedures for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 68: The US Historic Review for Tissue Transplantation by Tissue Type - Cornea, Heart Valves, Skin Grafts, Vascular Grafts, Bone Marrow and Bone Grafts Markets Independently Analyzed with Number of Procedures for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 69: The US 14-Year Perspective for Tissue Transplantation by Tissue Type - Percentage Breakdown of Number of Procedures for Cornea, Heart Valves, Skin Grafts, Vascular Grafts, Bone Marrow and Bone Grafts Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
    • Table 70: The US Recent Past, Current & Future Analysis for Bone Graft Transplantation by Graft Type - Autologous Graft, Allograft and Other Materials Markets Independently Analyzed with Number of Procedures for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 71: The US Historic Review for Bone Graft Transplantation by Graft Type - Autologous Graft, Allograft and Other Materials Markets Independently Analyzed with Number of Procedures for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 72: The US 14-Year Perspective for Bone Graft Transplantation by Graft Type - Percentage Breakdown of Number of Procedures for Autologous Graft, Allograft and Other Materials Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
    • Table 73: The US Recent Past, Current & Future Analysis for Bone Graft Transplantation by Application - General Orthopedics, Spinal Fusions and Cranio/Maxillofacial Markets Independently Analyzed with Number of Procedures for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 74: The US Historic Review for Bone Graft Transplantation by Application - General Orthopedics, Spinal Fusions and Cranio/ Maxillofacial Markets Independently Analyzed with Number of Procedures for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 75: The US 14-Year Perspective for Bone Graft Transplantation by Application - Percentage Breakdown of Number of Procedures for General Orthopedics, Spinal Fusions and Cranio/ Maxillofacial Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Current & Future Analysis
    • Canadians More Receptive to Organ Transplants
    • Table 76: Canadian Transplantation Market by Organ (2014): Percentage Breakdown of Number of Procedures for Hearts, Kidneys, Liver, Lungs and Pancreas (includes corresponding Graph/Chart)
    • Table 77: Canadian Organ Donors by Donor Type - Deceased and Living for Years 2011 - 2014 (includes corresponding Graph/Chart)
    • Table 78: Canadian Deceased Organ Donors by Age Group (2011-2014) (includes corresponding Graph/Chart)
    • Table 79: Canadian Living Organ Donors by Age Group (2011-2014) (includes corresponding Graph/Chart)
    • Waiting List
    • Table 80: Canadian Patients on Active Waiting List for Organ Transplants by Type: 2014 (includes corresponding Graph/Chart)
    • Success Rate of Organ Transplants
    • Table 81: Success Rate of Organ Transplants after 1-Year (includes corresponding Graph/Chart)
    • Favorable Growth Prospects in Bone Graft Substitutes Market
  • B. Market Analytics
    • Table 82: Canadian Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 83: Canadian Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 84: Canadian 14-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Current & Future Analysis
    • Terumo Corporation (Japan) - A Key Player
  • B. Market Analytics
    • Table 85: Japanese Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 86: Japanese Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 87: Japanese 14-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Current & Future Analysis
    • Table 88: European Deceased Organ Donors Per Million Population (PMP) in Select Leading Countries: 2013 & 2014 (includes corresponding Graph/Chart)
    • Table 89: European Multi-Organ Donors in Select Leading Countries: 2013 & 2014 (includes corresponding Graph/Chart)
    • Table 90: European Living Organ Donor Per Million Population (PMP) by Country for 2013 & 2014 (includes corresponding Graph/Chart)
    • Table 91: European Organ Transplantation by Organ in Select Leading Countries: 2014 (includes corresponding Graph/Chart)
    • Table 92: European Organ Transplantation Waiting Lists: No. of Waiting Patients by Organ Type (As of Month End - October 2015 and 2016) (includes corresponding Graph/Chart)
    • Table 93: European Organ Transplantation Waiting List by Organ in Select Leading Countries: 2014 (includes corresponding Graph/Chart)
    • Policy Changes - Key to Bridge Variability in Kidney Donors and Transplants across Europe
    • Focus on Select Regions
      • The United Kingdom
      • The UK Organ Transplantation System: An Overview
    • Table 94: Organ Donation in the UK by Type: Number of Deceased and Living Donors for Years 2013-14 through 2016-17 (includes corresponding Graph/Chart)
    • Table 95: Organ Donation in the UK by Country (2013-14 through 2016-17): Number of Donors by Type for England, Scotland, Norther Ireland and Wales (includes corresponding Graph/Chart)
    • Table 96: UK Organ Transplantation Market: Number of Transplants by Donor Type for Years 2013-14 through 2016-17 (includes corresponding Graph/Chart)
    • Table 97: UK Deceased Donor Organ Transplants: Number of Transplants by Organ Type for Years 2013-14 through 2015-16 (includes corresponding Graph/Chart)
    • Table 98: UK Organ Transplantation Market by Country (2013-14 through 2016-17): Number of Transplants by Type for England, Scotland, Norther Ireland and Wales (includes corresponding Graph/Chart)
    • Table 99: UK Organ Transplantation Waiting List: 2013-14 through 2016-17 (includes corresponding Graph/Chart)
    • Table 100: UK Organ Transplant Waiting List by Organ Types: 2014-15 through 2016-17 (includes corresponding Graph/Chart)
    • Table 101: Organ Donation in the UK (2015): Percentage Breakdown of Number of Donors by Age Group (includes corresponding Graph/Chart)
      • Spain
      • Organ Transplantation in Spain
      • France
      • Italy
      • Surge in Organ Transplants
      • Russia
      • Organ Transplantations Show a Downward Trend in Russia
      • Turkey
    • Table 102: Turkey - High PMP Numbers of Living Organ Donors/Transplants (includes corresponding Graph/Chart)
      • Akdeniz University - A World-Renowned Transplantation Center
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Table 103: European Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 104: European Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 105: European 14-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Current & Future Analysis
    • Table 106: Asia-Pacific Deceased Organ Donor Per Million Population (PMP) by Country for 2013 & 2015 (includes corresponding Graph/Chart)
    • Table 107: Asia-Pacific Living Organ Donor Per Million Population (PMP) by Country for 2011, 2013 & 2015 (includes corresponding Graph/Chart)
    • Thriving Orthopedic Biomaterials Market in Asia-Pacific
    • Focus on Select Regions
      • Australia - One of the Major Organ Transplant Markets in Asia-Pacific
      • Key Facts on Organ and Tissue Transplantation in Australia
      • Organ Transplantations Reach Record Highs
    • Table 108: Organ Donors in Australia by Type: Number of Consented and Actual Donors Years 2009, 2012 & 2015 (includes corresponding Graph/Chart)
    • Table 109: Organ Transplantation in Australia: Number of Organ Recipients and Transplantations for Years 2009 through 2015 (includes corresponding Graph/Chart)
    • Table 110: Organ Transplantation in Australia by Organ Type (2015): Number of Transplants for Heart, Kidney, Liver, Lung and Pancreas (includes corresponding Graph/Chart)
    • Table 111: Organ Transplantation Waiting in Australia by Organ Type: 2014 (includes corresponding Graph/Chart)
    • Table 112: Australian Organ Transplants by State: 2015 (includes corresponding Graph/Chart)
    • Table 113: Live Tissue Donations in Australia by Type (2013-2015): Number of Donations for Cardiovascular and Musculoskeletal Tissues (includes corresponding Graph/Chart)
    • Table 114: Deceased Tissue Donations in Australia by Type (2013-2015): Number of Organ & Tissue, and Tissue Only Donations for Cardiovascular, Musculoskeletal, Pancreas and Skin Tissues (includes corresponding Graph/Chart)
      • Government Efforts Key for Improving Organ Donation Activity
      • Government Mulls Easing Registration Process Further
      • China
      • Chinese Organ Transplant Market - Embroiled in Controversy
      • Transplantation Tourism in China
      • Low Transplant Success Rate Due to Unskilled Professionals
      • Illegal Activities for Harvesting Organs in China
      • Regulations on Organ Transplantation
      • Regulations on Brain Death
      • India
      • Organ Transplantation in India - Present Status
    • Table 115: Indian Organ Transplantation Market (2015): Current Requirement in Number of Organs by Type (includes corresponding Graph/Chart)
    • Table 116: Indian Organ Transplantation Market (2015): Number of Transplantations by Organ Type (includes corresponding Graph/Chart)
      • Rise in Medical Tourism Drives Bone Grafts Market
      • Aging Population Boosts the Indian Orthopedic Market
      • Overview of Renal Transplantation
      • Structural Deficiencies Affecting Indian Organ Donation Space
      • Singapore
      • Awareness Programs to Increase Living Kidney Donations in Singapore
    • Strategic Corporate Developments
  • B. Market Analytics
    • Table 117: Asia-Pacific Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 118: Asia-Pacific Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 119: Asia-Pacific 14-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

6. LATIN AMERICA

  • A. Market Analysis
    • Current & Future Analysis
    • Brazil - A Major Transplant Market
    • Dental Bone Graft Substitutes Market - Overview
    • Key Statistics
    • Table 120: Latin American Deceased Organ Donors Per Million Population (PMP) in Select Leading Countries: 2013 & 2014 (includes corresponding Graph/Chart)
    • Table 121: Latin American Multi-Organ Donors in Select Leading Countries: 2013 & 2014 (includes corresponding Graph/Chart)
    • Table 122: Latin American Living Organ Donor Per Million Population (PMP) by Country: 2013 & 2014 (includes corresponding Graph/Chart)
    • Table 123: Latin American Organ Transplantation by Organ in Select Leading Countries: 2014 (includes corresponding Graph/Chart)
    • Table 124: Latin American Organ Transplantation Waiting List by Organ in Select Leading Countries: 2014 (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 125: Latin American Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 126: Latin American Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 127: Latin American 14-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

7. REST OF WORLD

  • Market Analysis
    • Table 128: Rest of World Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 129: Rest of World Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 130: Rest of World 14-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

COMPETITIVE LANDSCAPE

Back to Top